Möchten Sie immer auf dem neuesten Stand bleiben?

New Orleans, LA, June 09, 2026 (GLOBE NEWSWIRE) -- Loyola University New Orleans today announced that Wolf Pack Athletics has been accepted as a member of the Gulf South Conference (GSC), a Division...

WestGene’s established targeted LNP platform combined with Cartesian’s mRNA payload from Descartes-08 integrates two independently, clinically tested technologies for rapid clinical translation Plans...

AI Era Corp Enters into Agreement with BCII Enterprises to License Coupon and Super Coupon Technology Platform

       AUTOMATIC SHARE PURCHASE PLAN London, 5 June 2026 – Endeavour Mining Plc (LEI: 529900NI5MXQ91GHXR07, LSE: EDV, TSX: EDV, OTCQX:EDVMF) (“the Company”) has re-entered into an Automatic Share...

– Multi-target agreement positions Stipple Bio to advance next-generation ADC therapies using Lonza’s clinically validated ADC platform — — Stipple Bio’s Pointillist Platform identifies...

Agios announces an agreement with Oscotec to license the exclusive global rights to cevidoplenib, a novel, next generation, oral SYK inhibitor

Orelabrutinib (HIBRUKA®) has been approved by TGA in Australia, offering a new treatment option for patients with R/R MCL in the region.

London, May 26, 2026 (GLOBE NEWSWIRE) -- Gordon Brothers, the global asset experts, has acquired the Radley brand and related intellectual property. As the new brand owner, the firm will drive a...

SKYX Signs a Licensing Agreement for Its Advanced Technologies with U.S., Canada, and Global Leading Lighting Company Eurofase

PharmAla Biotech Signs Term Sheet to License Exclusive U.S. Rights to ALA-002 to Jupiter Neurosciences in a Transaction Valued at Over $100 Million USD